Nefrologia

Prevenção e tratamento da hipercalemia em pacientes tratados com inibidores do sistema renina-angiotensina-aldosterona.

8 Dez, 2021 | 13:07h

Prevention and management of hyperkalemia in patients treated with renin–angiotensin–aldosterone system inhibitors – Canadian Medical Association Journal

Diretriz | Tratamento de cálculos ureterais.

2 Dez, 2021 | 11:22h

Canadian Urological Association guideline: Management of ureteral calculi – Abridged version – Canadian Urological Association Journal

Diretrizes relacionadas:

Renal and ureteric stones: assessment and management – National Institute for Health and Care Excellence

Dietary and Pharmacologic Management to Prevent Recurrent Nephrolithiasis in Adults: A Clinical Practice Guideline From the American College of Physicians

Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement – Journal of Nephrology

The Urological Association of Asia clinical guideline for urinary stone disease – International Journal of Urology

Estudo de coorte | Momento do início da diálise para reduzir a mortalidade e os eventos cardiovasculares na doença renal crônica avançada.

2 Dez, 2021 | 11:16h

Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study – The BMJ

Comentário do autor no Twitter (fio – clique para saber mais)

Why did observational studies find ⬆️survival for late dialysis initiation, whereas the IDEAL RCT found no difference? Was it confounding, the usual culprit we point to? No!

Our new paper @bmj_latest addresses this and much more! #epitwitter #nephtwitter https://t.co/rILigIojR1 pic.twitter.com/zDxpQMqnfE

— Edouard L. Fu (@FuEdouard) December 1, 2021

Podcast | Alcalose metabólica e hipocalemia.

30 Nov, 2021 | 12:06h

#308 Metabolic Alkalosis and Hypokalemia: Kidney Boy Returns! – The Curbsiders

Revisão sistemática | Denervação renal pode ter um efeito modesto em melhorar a pressão no monitoramento ambulatorial da pressão arterial (MAPA) em 24 horas (redução de 5,29 mmHg na pressão arterial sistólica e de 3,75 mmHg na diastólica), mas não melhora desfechos cardiovasculares maiores e a função renal.

24 Nov, 2021 | 11:22h

Resumo: Renal denervation for improving outcomes in individuals with resistant hypertension – Cochrane Library

Revisão original: Renal denervation for resistant hypertension – Cochrane Library

Conteúdo relacionado: M-A: Renal denervation for hypertension is associated with a modest reduction in ambulatory blood pressure control (3.61 mm Hg reduction in ambulatory systolic BP and 1.85 mm Hg reduction in ambulatory diastolic BP).

Comentário no Twitter

Does renal #denervation improve outcomes in people with resistant #hypertension?❤️

Our newly updated @CochraneLibrary #SystematicReview looks at the evidence of 15 RCTs involving 1416 participants: https://t.co/NkVMHW46s6 #CochraneEvidence #blogshot pic.twitter.com/TBqli3e9ai

— Cochrane Hypertension (@CochraneHTN) November 23, 2021

Em uma pesquisa com cerca de 27.600 indivíduos nos EUA, 18,5% dos adultos com hipertensão utilizavam medicamentos que podem aumentar a pressão arterial; as classes mais comumente relatadas foram antidepressivos, anti-inflamatórios não hormonais, corticosteroides e estrogênios.

23 Nov, 2021 | 15:44h

Prevalence of Medications That May Raise Blood Pressure Among Adults With Hypertension in the United States – JAMA Internal Medicine (gratuito por tempo limitado)

Comentário do autor no Twitter (fio – clique para saber mais)

🚨New work from our team in @JAMAInternalMed 🚨

18% of adults with #hypertension report using medications (💊) that may raise blood pressure.

Use of these 💊 associated with:
⬇️ odds of achieving BP control
⬆️ # of antihypertensives usedhttps://t.co/DlV5rlHLu3

Thread
/1 pic.twitter.com/q7b7FQ4jHH

— Tim Anderson (@TimAndersonMD) November 22, 2021